{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:48:08Z","timestamp":1792417688271,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM142975"],"award-info":[{"award-number":["R35GM142975"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We describe a strategy to boost the efficiency of gene editing via homology-directed repair (HDR) by covalently modifying the template DNA with interstrand crosslinks. Crosslinked templates (xHDRTs) increase Cas9-mediated editing efficiencies by up to fivefold in K562, HEK293T, U2OS, iPS and primary T cells. Increased editing from xHDRTs is driven by events on the template molecule and requires ataxia telangiectasia and Rad3-related (ATR) kinase and components of the Fanconi anemia pathway.<\/jats:p>","DOI":"10.1038\/s41587-022-01654-y","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T12:02:58Z","timestamp":1677499378000},"page":"1398-1404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interstrand crosslinking of homologous repair template DNA enhances gene editing in human cells"],"prefix":"10.1038","volume":"41","author":[{"given":"Hannah I.","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine U.","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3122-4851","authenticated-orcid":false,"given":"Chris D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"1654_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","volume":"82","author":"TS Nambiar","year":"2022","unstructured":"Nambiar, T. S., Baudrier, L., Billon, P. & Ciccia, A. CRISPR-based genome editing through the lens of DNA repair. Mol. Cell 82, 348\u2013388 (2022).","journal-title":"Mol. Cell"},{"key":"1654_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.4313","volume":"23","author":"TI Cornu","year":"2017","unstructured":"Cornu, T. I., Mussolino, C. & Cathomen, T. Refining strategies to translate genome editing to the clinic. Nat. Med. 23, 415\u2013423 (2017).","journal-title":"Nat. Med."},{"key":"1654_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"1654_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J.-S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012\u20131019 (2014).","journal-title":"Genome Res."},{"key":"1654_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coi.2019.03.007","volume":"59","author":"CS Azimi","year":"2019","unstructured":"Azimi, C. S., Tang, Q., Roybal, K. T. & Bluestone, J. A. NextGen cell-based immunotherapies in cancer and other immune disorders. Curr. Opin. Immunol. 59, 79\u201387 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"1654_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli, M. The CRISPR tool kit for genome editing and beyond. Nat. Commun. 9, 1911 (2018).","journal-title":"Nat. Commun."},{"key":"1654_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","volume":"38","author":"J van Haasteren","year":"2020","unstructured":"van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N. & Schaffer, D. V. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat. Biotechnol. 38, 845\u2013855 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1654_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41587-019-0325-6","volume":"38","author":"DN Nguyen","year":"2020","unstructured":"Nguyen, D. N. et al. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency. Nat. Biotechnol. 38, 44\u201349 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1654_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nmeth.1653","volume":"8","author":"F Chen","year":"2011","unstructured":"Chen, F. et al. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat. Methods 8, 753 (2011).","journal-title":"Nat. Methods"},{"key":"1654_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/acschembio.7b00760","volume":"13","author":"DN Gallagher","year":"2018","unstructured":"Gallagher, D. N. & Haber, J. E. Repair of a site-specific DNA cleavage: old-school lessons for Cas9-mediated gene editing. ACS Chem. Biol. 13, 397\u2013405 (2018).","journal-title":"ACS Chem. Biol."},{"key":"1654_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01875-9","volume":"8","author":"J Carlson-Stevermer","year":"2017","unstructured":"Carlson-Stevermer, J. et al. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing. Nat. Commun. 8, 1711 (2017).","journal-title":"Nat. Commun."},{"key":"1654_CR12","doi-asserted-by":"publisher","first-page":"e25312","DOI":"10.7554\/eLife.25312","volume":"6","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering. eLife 6, e25312 (2017).","journal-title":"eLife"},{"key":"1654_CR13","doi-asserted-by":"publisher","first-page":"eaaz0051","DOI":"10.1126\/sciadv.aaz0051","volume":"6","author":"X Ling","year":"2020","unstructured":"Ling, X. et al. Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates. Sci. Adv. 6, eaaz0051 (2020).","journal-title":"Sci. Adv."},{"key":"1654_CR14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41588-018-0174-0","volume":"50","author":"CD Richardson","year":"2018","unstructured":"Richardson, C. D. et al. CRISPR\u2013Cas9 genome editing in human cells occurs via the Fanconi anemia pathway. Nat. Genet. 50, 1132\u20131139 (2018).","journal-title":"Nat. Genet."},{"key":"1654_CR15","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1016\/j.cell.2021.10.002","volume":"184","author":"JA Hussmann","year":"2021","unstructured":"Hussmann, J. A. et al. Mapping the genetic landscape of DNA double-strand break repair. Cell 184, 5653\u20135669 (2021).","journal-title":"Cell"},{"key":"1654_CR16","doi-asserted-by":"publisher","first-page":"e04766","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. eLife 3, e04766 (2014).","journal-title":"eLife"},{"key":"1654_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nbt.4021","volume":"36","author":"MD Canny","year":"2018","unstructured":"Canny, M. D. et al. Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency. Nat. Biotechnol. 36, 95\u2013102 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1654_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1073\/pnas.0407796102","volume":"102","author":"K Nakanishi","year":"2005","unstructured":"Nakanishi, K. et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl Acad. Sci. USA 102, 1110\u20131115 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1654_CR19","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/emboj.2009.193","volume":"28","author":"C Roques","year":"2009","unstructured":"Roques, C. et al. MRE11-RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair. EMBO J. 28, 2400\u20132413 (2009).","journal-title":"EMBO J."},{"key":"1654_CR20","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1093\/nar\/gks670","volume":"40","author":"M Enoiu","year":"2012","unstructured":"Enoiu, M., Jiricny, J. & Sch\u00e4rer, O. D. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res. 40, 8953\u20138964 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1654_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/nar\/gku1279","volume":"43","author":"T Iyama","year":"2015","unstructured":"Iyama, T. et al. CSB interacts with SNM1A and promotes DNA interstrand crosslink processing. Nucleic Acids Res. 43, 247\u2013258 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1654_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-biochem-080320-112510","volume":"90","author":"DR Semlow","year":"2021","unstructured":"Semlow, D. R. & Walter, J. C. Mechanisms of vertebrate DNA interstrand cross-link repair. Annu. Rev. Biochem. 90, 107\u2013135 (2021).","journal-title":"Annu. Rev. Biochem."},{"key":"1654_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/tx00008a001","volume":"2","author":"JE Hearst","year":"1989","unstructured":"Hearst, J. E. Photochemistry of the psoralens. Chem. Res. Toxicol. 2, 69\u201375 (1989).","journal-title":"Chem. Res. Toxicol."},{"key":"1654_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/ed083p728","volume":"83","author":"RA Alderden","year":"2006","unstructured":"Alderden, R. A., Hall, M. D. & Hambley, T. W. The discovery and development of cisplatin. J. Chem. Educ. 83, 728 (2006).","journal-title":"J. Chem. Educ."},{"key":"1654_CR25","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1093\/nar\/gkg402","volume":"31","author":"PJ Rochette","year":"2003","unstructured":"Rochette, P. J. UVA-induced cyclobutane pyrimidine dimers form predominantly at thymine-thymine dipyrimidines and correlate with the mutation spectrum in rodent cells. Nucleic Acids Res. 31, 2786\u20132794 (2003).","journal-title":"Nucleic Acids Res."},{"key":"1654_CR26","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152\u20139159 (2004).","journal-title":"Cancer Res."},{"key":"1654_CR27","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1021\/jm301859s","volume":"56","author":"KM Foote","year":"2013","unstructured":"Foote, K. M. et al. Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity. J. Med. Chem. 56, 2125\u20132138 (2013).","journal-title":"J. Med. Chem."},{"key":"1654_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0215-6","volume":"7","author":"F Robert","year":"2015","unstructured":"Robert, F., Barbeau, M., \u00c9thier, S., Dostie, J. & Pelletier, J. Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med. 7, 93 (2015).","journal-title":"Genome Med."},{"key":"1654_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17962-3","volume":"11","author":"P Roidos","year":"2020","unstructured":"Roidos, P. et al. A scalable CRISPR\/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice. Nat. Commun. 11, 4077 (2020).","journal-title":"Nat. Commun."},{"key":"1654_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-genet-110410-132435","volume":"45","author":"LS Symington","year":"2011","unstructured":"Symington, L. S. & Gautier, J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45, 247\u2013271 (2011).","journal-title":"Annu. Rev. Genet."},{"key":"1654_CR31","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1073\/pnas.0308717101","volume":"101","author":"S Cantor","year":"2004","unstructured":"Cantor, S. et al. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl Acad. Sci. USA 101, 2357\u20132362 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1654_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801\u2013817 (2017).","journal-title":"Mol. Cell"},{"key":"1654_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15845-1","volume":"11","author":"B Wienert","year":"2020","unstructured":"Wienert, B. et al. Timed inhibition of CDC7 increases CRISPR\u2013Cas9 mediated templated repair. Nat. Commun. 11, 2109 (2020).","journal-title":"Nat. Commun."},{"key":"1654_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymeth.2019.06.016","volume":"164\u2013165","author":"WC Skarnes","year":"2019","unstructured":"Skarnes, W. C., Pellegrino, E. & McDonough, J. A. Improving homology-directed repair efficiency in human stem cells. Methods 164\u2013165, 18\u201328 (2019).","journal-title":"Methods"},{"key":"1654_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01654-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01654-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:08:20Z","timestamp":1697051300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01654-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1038\/s41587-022-01654-y","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.I.G. and C.D.R. are inventors of patent applications based on the findings described in this paper. J.B., A.C.Y., K.U.T., C.C., J.T.V. and B.M.G. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}